Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)

Jing Gao; Bo Hou; Qiwen Zhu; Lei Yang; Xingyu Jiang; Zhifeng Zou; Xutong Li; Tianfeng Xu; Mingyue Zheng; Yi Hung Chen; Zhiai Xu; Huixiong Xu; Haijun Yu

doi:10.1038/s41467-022-32722-1

Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)

Jing Gao
, Bo Hou
, Qiwen Zhu
, Lei Yang
, Xingyu Jiang
, Zhifeng Zou
, Xutong Li
, Tianfeng Xu
, Mingyue Zheng
, Yi Hung Chen
, Zhiai Xu^*
, Huixiong Xu^*
, Haijun Yu^*

^*Corresponding author for this work

School of Chemistry and Molecular Engineering

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

The original version of this Article contained an error in Figures 6k (PED + N3@PGDA7 + Laser) and 6l (PED + N3@PGDA7), in which the images were duplicates of adjacent images and the correct imagesweremissing. This has been corrected in both the PDF andHTML versions of the Article.

Original language	English
Article number	4978
Journal	Nature Communications
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41467-022-32722-1
State	Published - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41467-022-32722-1

Fingerprint

Dive into the research topics of 'Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)'. Together they form a unique fingerprint.

Cite this

Gao, J., Hou, B., Zhu, Q., Yang, L., Jiang, X., Zou, Z., Li, X., Xu, T., Zheng, M., Chen, Y. H., Xu, Z., Xu, H., & Yu, H. (2022). Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4). Nature Communications, 13(1), Article 4978. https://doi.org/10.1038/s41467-022-32722-1

@article{45021a0430634f7684a4ba6a068c8a9f,

title = "Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)",

abstract = "The original version of this Article contained an error in Figures 6k (PED + N3@PGDA7 + Laser) and 6l (PED + N3@PGDA7), in which the images were duplicates of adjacent images and the correct imagesweremissing. This has been corrected in both the PDF andHTML versions of the Article.",

author = "Jing Gao and Bo Hou and Qiwen Zhu and Lei Yang and Xingyu Jiang and Zhifeng Zou and Xutong Li and Tianfeng Xu and Mingyue Zheng and Chen, \{Yi Hung\} and Zhiai Xu and Huixiong Xu and Haijun Yu",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1038/s41467-022-32722-1",

language = "英语",

volume = "13",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

Gao, J, Hou, B, Zhu, Q, Yang, L, Jiang, X, Zou, Z, Li, X, Xu, T, Zheng, M, Chen, YH, Xu, Z, Xu, H & Yu, H 2022, 'Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)', Nature Communications, vol. 13, no. 1, 4978. https://doi.org/10.1038/s41467-022-32722-1

TY - JOUR

T1 - Author Correction

T2 - Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)

AU - Gao, Jing

AU - Hou, Bo

AU - Zhu, Qiwen

AU - Yang, Lei

AU - Jiang, Xingyu

AU - Zou, Zhifeng

AU - Li, Xutong

AU - Xu, Tianfeng

AU - Zheng, Mingyue

AU - Chen, Yi Hung

AU - Xu, Zhiai

AU - Xu, Huixiong

AU - Yu, Haijun

PY - 2022/12

Y1 - 2022/12

N2 - The original version of this Article contained an error in Figures 6k (PED + N3@PGDA7 + Laser) and 6l (PED + N3@PGDA7), in which the images were duplicates of adjacent images and the correct imagesweremissing. This has been corrected in both the PDF andHTML versions of the Article.

AB - The original version of this Article contained an error in Figures 6k (PED + N3@PGDA7 + Laser) and 6l (PED + N3@PGDA7), in which the images were duplicates of adjacent images and the correct imagesweremissing. This has been corrected in both the PDF andHTML versions of the Article.

UR - https://www.scopus.com/pages/publications/85136631577

U2 - 10.1038/s41467-022-32722-1

DO - 10.1038/s41467-022-32722-1

M3 - 评论/辩论

C2 - 36008490

AN - SCOPUS:85136631577

SN - 2041-1723

VL - 13

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 4978

ER -

Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this